| 000 |
|
01744nam0 2200301 450 |
| 001 |
|
1000179451 |
| 005 |
|
20200629162517.0 |
| 010 |
__ |
■a978-7-03-062892-3■dCNY260.00 |
| 100 |
__ |
■a20200102d2020 em y0chiy50 ea |
| 101 |
1_ |
■achi■ceng |
| 102 |
__ |
■aCN■b110000 |
| 105 |
__ |
■aa z 000yy |
| 106 |
__ |
■ar |
| 200 |
1_ |
■a药物代谢动力学技术在药物设计和开发中的应用■d= ADME-enabling technologies in dru+...... |
| 210 |
__ |
■a北京■c科学出版社■d2020.01 |
| 215 |
__ |
■axxv, 574页■c图■d26cm |
| 225 |
2_ |
■a药明康德经典译译丛■Ayao ming kang de jing dian yi yi cong |
| 314 |
__ |
■a责任者规范汉译姓: 雷蒙德常 |
| 330 |
__ |
■a本书是由多位活跃在中国、美国各大制药公司和研究机构的药物代谢学家根据他们的工作经验和实践撰写的。本书包括四个部分, +...... |
| 410 |
_0 |
■12001 ■a药明康德经典译译丛 |
| 500 |
10 |
■aADME-enabling technologies in drug design and development■+...... |
| 606 |
0_ |
■a药物代谢动力学■x研究■Ayao wu dai xie dong li xue |
| 690 |
__ |
■aR969.1■v5 |
| 701 |
_1 |
■a雷蒙德常■g(Zhang, DongLu)■4编■Alei meng de chang |
| 701 |
_1 |
■aSurapaneni,■bSekhar■4编 |
| 712 |
02 |
■a上海药明康德新药开发公司■4译■Ashang hai yao ming kang de xin yao kai fa+...... |
| 801 |
|
■aCN■bGSXY■c20200629 |
| 905 |
|
■aGSXY■fR969.1/L515■g1400804 |
(共0票)
评价
